CME Test for AMDA Clinical Practice Guideline. Diabetes Mellitus

Size: px
Start display at page:

Download "CME Test for AMDA Clinical Practice Guideline. Diabetes Mellitus"

Transcription

1 CME Test for AMDA Clinical Practice Guideline Diabetes Mellitus Part I: 1. Which one of the following statements about type 2 diabetes is not accurate? a. Diabetics are at increased risk of experiencing depression. b. Neither cognitive impairment nor dementia occurs more frequently than in nondiabetics. c. Heart attacks and strokes are at least twice as frequent in diabetics than in comparison subjects. d. Autonomic neuropathy may contribute to sexual dysfunction in type 2 diabetics. 2. Three major surveys, two conducted in the US and one in the United Kingdom, found that approximately of residents in nursing facilities have diabetes. a. 10% b. 15% to 30% c. 30% to 40% d. 40% to 50% 3. The hyperosmolar hyperglycemic state, a serious complication of type 2 diabetes in older individuals, is a result of: a. decreased insulin activity. b. increased output of glucose by the liver and kidneys. c. increased serum osmolality d. all of these. 4. The risk of developing type 2 diabetes is NOT increased by: a. occasional intake of large amounts of sugar-rich foods. b. having an infant weighing more than 9 pounds at birth. c. being an African-American. d. having a diabetic sibling. 5. All of the following EXCEPT may be a presenting feature of type 2 diabetes in elderly individuals. a. a recent gain in body weight b. a recent loss of body weight c. skin infection d. decreased pain perception 6. Hyperglycemia not secondary to type 2 diabetes may be a result of treatment with: a. conventional antipsychotic drugs. b. newer antipsychotic drugs. c. either of these. d. neither of these.

2 AMDA Test on Diabetes Mellitus CPG page 2 7. Hyperglycemia in older non-diabetic adults who have pancreatitis, pancreatic cancer, or injury to the pancreas as well as those undergoing pancreatectomy. a. is not observed b. may be detected 8. The oral glucose tolerance test: a. is mandatory when working up individuals who may have type 2 diabetes. b. should be performed at regular intervals when following those already diagnosed with diabetes. c. is not recommended for routine clinical use. 9. With respect to the dietary management of residents with diabetes, which statement is correct? a. The concept of a diabetic diet and diets excluding concentrated sweets or added sugar remains valid. b. Lowering the intake of sucrose-sweetened foods will reliably improve glycemic control. c. A restricted diet rarely compromises the quality of life for frail, elderly patients. d. For obese diabetics who are unable to lose weight for any reason, maintaining near-normal blood glucose levels as tolerated is a reasonable alternative. 10. When refining the management of diabetic patients: a. doses of oral antidiabetic agents, and insulin if used, should be adjusted to properly balance food consumption. b. food consumption should be adjusted to balance current doses of oral antidiabetic agents and insulin. 11. A relevant consideration when deciding on whether to institute combination therapy with multiple oral antidiabetic drugs is that: a. two secretagogues drugs that promote the production or release of insulin have been proved to have additive effects b. combination drug treatment may be tried when monotherapy has failed when the criterion fasting plasma glucose value is above140 mg/dl. c. if two-drug treatment fails and improved glycemic control is considered important for a given patient, adding a third oral agent of the same class may prove effective. 12. A physician who chooses to administer a sulfonylurea drug in an attempt to enhance insulin secretion by the pancreatic islet beta cells should be aware that: a. first-generation sulfonylurea drugs such as tolbutamide or tolazamide are less likely to cause hypoglycemia than are second-generation drugs such as glyburide or glipizide. b. sulfonylurea drugs commonly are associated with weight loss. c. chlorpropamide should not be prescribed for elderly patients. d. first-generation sulfonylurea drugs are preferable for patients with kidney or liver disease. 13. Alpha-glucosidase inhibitors, which slow the digestion of carbohydrates, thereby allowing time for increased insulin secretion, are either sulfonylurea drugs or biguanides to cause hypoglycemia. a. more likely than b. less likely than

3 AMDA Test on Diabetes Mellitus CPG page Which of these statements about the thiazolidinedione class of oral antidiabetic agents is NOT accurate? a. These drugs reduce insulin resistance by promoting insulin-mediated glucose uptake in muscle, fat tissue, and the liver, and by lowering hepatic glucose output. b. They may cause severe liver toxicity. c. They are contraindicated in patients with mild congestive heart failure. d. They have only a modest effect on blood glucose levels. 15. The meglitinides are relatively short-acting insulin secretagogues distinct from the sulfonylurea drugs that act by stimulating insulin secretion. These drugs: a. effectively lower blood glucose levels. b. elevate blood lipid levels. c. do not alter body weight. d. may pose a greater risk of hypoglycemia than do the sulfonylurea drugs. 16. The biguanides such as metformin do NOT: a. suppress hepatic glucose production. b. make muscle tissue more sensitive to insulin. c. increase blood levels of triglyceride and low-density-lipoprotein cholesterol. d. constitute a contraindication for diabetic patients whose renal function is impaired. 17. Indications for the immediate use of insulin include: a. significant weight loss. b. a hyperosmolar state. c. surgery. d. any of these conditions. e. none of these conditions. 18. An expressed wish of a patient with type 2 diabetes to receive insulin as a part of initial treatment a legitimate reason to add insulin to a regimen of diet, exercise, and oral antidiabetic medication. a. is b. is not 19. Even if there are no symptoms or signs of hypoglycemia, immediate attention by a physician is warranted if a patient s blood glucose is lower than mg/dl. a. 50 b. 60 c. 75 d At present, the preferred initial type of drug for use in a patient with type 2 diabetes who is hypertensive and has either microalbuminuria or clinical albuminuria is: a. a diuretic. b. a beta-blocker. c. an angiotensin-converting enzyme (ACE) inhibitor. d. an angiotensin II-receptor blocker.

4 AMDA Test on Diabetes Mellitus page Neuropathic complications of type 2 diabetes may include: a. chronic constipation. b. diarrhea. c. either of these conditions. d. neither of these conditions. 22. Measures to lower elevated blood lipid levels in long-term care patients with type 2 diabetes: a. are mandatory. b. may be unnecessary when hyperlipidemia is reversed by better glycemic control. c. have proved in large-scale randomized trials to lower the risk of heart attacks and strokes. d. entail virtually no risk of causing undernutrition. 23. Annual vaccination against influenza is advisable in long-term care patients who are diabetic. In addition, pneumococcal vaccine is recommended: a. if it is not clear whether the patient has previously been vaccinated. b. if fewer than 5 years have elapsed since the last vaccination in a patient less than 65 years of age. c. if the patient was aged 65 or older when last vaccinated. 24. The minimum interval for monitoring blood glucose in diabetic patients who are well controlled while taking an oral antidiabetic drug or drugs, assuming no change in type of drug or dosage, is: a. once a day. b. every other day. c. twice a week. d. once a week. Part II: Effectiveness of Activity: 1. This activity reinforced my current practice. Yes No 2. This activity made me look at the treatment of diabetes in new ways. Yes No 3. I will implement the following new practices into my treatment plans: 4. This CPG activity has been a good educational (circle one): review intervention. 5. Please provide a follow-up activity on implementation with the interdisciplinary team. Yes No

5 Part III: Request for CME Certificate: I attest to having completed the self-directed study on the CPG Diabetes Mellitus and request 2 credit hours in category 1 toward the AMA PRA. Signature Date Credit certificate will be sent by unless you indicate preference for using fax. PRINT legibly or type: Name Address Telephone number FAX number Return this CME Post-Test with the $14 fee to AMDA Education via to by fax to (410) ; or by mail to AMDA, Education Department, Broken Land Parkway, Suite 400, Columbia, MD Please allow 4 weeks for processing your certificate. If you choose to or to print and fax your test, please provide credit card payment: Type of Card: MasterCard Visa American Express Card # Security Code Expiration Date Cardholder Name Cardholder s Signature IF YOU FAX YOUR TEST, PLEASE BE SURE TOFAX ALL FIVE PAGES.

Nutrition. Type 2 Diabetes: A Growing Challenge in the Healthcare Setting NAME OF STUDENT

Nutrition. Type 2 Diabetes: A Growing Challenge in the Healthcare Setting NAME OF STUDENT 1 Nutrition Type 2 Diabetes: A Growing Challenge in the Healthcare Setting NAME OF STUDENT 2 Type 2 Diabetes: A Growing Challenge in the Healthcare Setting Introduction and background of type 2 diabetes:

More information

Type 2 diabetes Definition

Type 2 diabetes Definition Type 2 diabetes Definition Type 2 diabetes is a lifelong (chronic) disease in which there are high levels of sugar (glucose) in the blood. Type 2 diabetes is the most common form of diabetes. Causes Diabetes

More information

Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both.

Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both. Diabetes Definition Diabetes is a chronic (lifelong) disease marked by high levels of sugar in the blood. Causes Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused

More information

Causes, incidence, and risk factors

Causes, incidence, and risk factors Causes, incidence, and risk factors Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both. To understand diabetes,

More information

CLINICAL PRACTICE GUIDELINE

CLINICAL PRACTICE GUIDELINE CLINICAL PRACTICE GUIDELINE Procedure: Diabetes Guideline Review Cycle: Biennial Reviewed By: Amish Purohit, MD, MHA, CPE, FACHE Review Date: November 2014 Committee Approval Date: 11/12/2014 PURPOSE:

More information

DIABETES MEDICATION-ORAL AGENTS AND OTHER HYPOGLYCEMIC AGENTS

DIABETES MEDICATION-ORAL AGENTS AND OTHER HYPOGLYCEMIC AGENTS Section Two DIABETES MEDICATION-ORAL AGENTS AND OTHER HYPOGLYCEMIC AGENTS This section will: Describe oral agents (pills) are specific for treating type 2 diabetes. Describe other hypoglycemic agents used

More information

Type II diabetes: How to use the new oral medications

Type II diabetes: How to use the new oral medications Type II diabetes: How to use the new oral medications A TWO-PART INTERVIEW WITH NANCY J.V. BOHANNON, MD, BY DAVID B. JACK, MD Several new oral drugs have been approved for the management of type II diabetes.

More information

There seem to be inconsistencies regarding diabetic management in

There seem to be inconsistencies regarding diabetic management in Society of Ambulatory Anesthesia (SAMBA) Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery Review of the consensus statement and additional

More information

EFFIMET 1000 XR Metformin Hydrochloride extended release tablet

EFFIMET 1000 XR Metformin Hydrochloride extended release tablet BRAND NAME: Effimet XR. THERAPEUTIC CATEGORY: Anti-Diabetic PHARMACOLOGIC CLASS: Biguanides EFFIMET 1000 XR Metformin Hydrochloride extended release tablet COMPOSITION AND PRESENTATION Composition Each

More information

TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION. Robert Dobbins, M.D. Ph.D.

TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION. Robert Dobbins, M.D. Ph.D. TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION Robert Dobbins, M.D. Ph.D. Learning Objectives Recognize current trends in the prevalence of type 2 diabetes. Learn differences between type 1 and type

More information

EXPLORING THE INTERACTION BETWEEN EXERCISE AND MEDICATION FOR CHRONIC DISEASE: CONSIDERATIONS FOR FITNESS PROFESSIONALS

EXPLORING THE INTERACTION BETWEEN EXERCISE AND MEDICATION FOR CHRONIC DISEASE: CONSIDERATIONS FOR FITNESS PROFESSIONALS EXPLORING THE INTERACTION BETWEEN EXERCISE AND MEDICATION FOR CHRONIC DISEASE: CONSIDERATIONS FOR FITNESS PROFESSIONALS Steven T. Johnson, PhD 1 Introduction The prevalence of chronic diseases like cardiovascular

More information

Medications for Diabetes

Medications for Diabetes AGS Diab Med Brochure 4/18/03 3:43 PM Page 1 Medications for Diabetes An Older Adult s Guide to Safe Use of Diabetes Medications THE AGS FOUNDATION FOR HEALTH IN AGING AGS Diab Med Brochure 4/18/03 3:43

More information

Diabetes mellitus. Lecture Outline

Diabetes mellitus. Lecture Outline Diabetes mellitus Lecture Outline I. Diagnosis II. Epidemiology III. Causes of diabetes IV. Health Problems and Diabetes V. Treating Diabetes VI. Physical activity and diabetes 1 Diabetes Disorder characterized

More information

Baskets of Care Diabetes Subcommittee

Baskets of Care Diabetes Subcommittee Baskets of Care Diabetes Subcommittee Disclaimer: This background information is not intended to be a comprehensive scientific discussion of the topic, but rather an attempt to provide a baseline level

More information

Diabetes Fundamentals

Diabetes Fundamentals Diabetes Fundamentals Prevalence of Diabetes in the U.S. Undiagnosed 10.7% of all people 20+ 23.1% of all people 60+ (12.2 million) Slide provided by Roche Diagnostics Sources: ADA, WHO statistics Prevalence

More information

Am I at Risk for type 2 Diabetes? Taking Steps to Lower the Risk of Getting Diabetes NATIONAL DIABETES INFORMATION CLEARINGHOUSE

Am I at Risk for type 2 Diabetes? Taking Steps to Lower the Risk of Getting Diabetes NATIONAL DIABETES INFORMATION CLEARINGHOUSE NATIONAL DIABETES INFORMATION CLEARINGHOUSE Am I at Risk for type 2 Diabetes? Taking Steps to Lower the Risk of Getting Diabetes U.S. Department of Health and Human Services National Institutes of Health

More information

CHRONIC KIDNEY DISEASE PRACTICE GUIDELINES

CHRONIC KIDNEY DISEASE PRACTICE GUIDELINES CHRONIC KIDNEY DISEASE PRACTICE GUIDELINES Reviewed and approved 5/2014 Risk Chronic kidney disease is defined as either kidney damage or decreased kidney function (decreased GFR) for 3 or more months.

More information

Is Insulin Effecting Your Weight Loss and Your Health?

Is Insulin Effecting Your Weight Loss and Your Health? Is Insulin Effecting Your Weight Loss and Your Health? Teressa Alexander, M.D., FACOG Women s Healthcare Associates www.rushcopley.com/whca 630-978-6886 Obesity is Epidemic in the US 2/3rds of U.S. adults

More information

Diabetes Mellitus Type 2

Diabetes Mellitus Type 2 Diabetes Mellitus Type 2 What is it? Diabetes is a common health problem in the U.S. and the world. In diabetes, the body does not use the food it digests well. It is hard for the body to use carbohydrates

More information

COST ANALYSIS OF ANTIDIABETIC DRUGS FOR DIABETES MELLITUS OUTPATIENT IN KODYA YOGYAKARTA HOSPITAL

COST ANALYSIS OF ANTIDIABETIC DRUGS FOR DIABETES MELLITUS OUTPATIENT IN KODYA YOGYAKARTA HOSPITAL Malaysian Journal of Pharmaceutical Sciences, Vol. 5, No. 1, 19 23 (2007) COST ANALYSIS OF ANTIDIABETIC DRUGS FOR DIABETES MELLITUS OUTPATIENT IN KODYA YOGYAKARTA HOSPITAL TRI MURTI ANDAYANI* AND IKE IMANINGSIH

More information

1 of 8 Guidelines for Management of the Elderly with Diabetes in Long-Term Care Facilities

1 of 8 Guidelines for Management of the Elderly with Diabetes in Long-Term Care Facilities for Management of the Elderly with Diabetes in Long-Term Care Facilities S U P P L E M E N T Introduction High Risk for Diabetes-related Complications The elderly in long-term care facilities such as nursing

More information

Section 5: Type 2 Diabetes

Section 5: Type 2 Diabetes SECTION OVERVIEW Definition and Symptoms Blood Glucose Monitoring Healthy Eating Physical Activity Oral Medication Insulin Sharps Disposal Definition and Symptoms Type 2 diabetes is occurring more frequently

More information

Statistics of Type 2 Diabetes

Statistics of Type 2 Diabetes Statistics of Type 2 Diabetes Of the 17 million Americans with diabetes, 90 percent to 95 percent have type 2 diabetes. Of these, half are unaware they have the disease. People with type 2 diabetes often

More information

Tuberculosis And Diabetes. Dr. hanan abuelrus Prof.of internal medicine Assiut University

Tuberculosis And Diabetes. Dr. hanan abuelrus Prof.of internal medicine Assiut University Tuberculosis And Diabetes Dr. hanan abuelrus Prof.of internal medicine Assiut University TUBERCULOSIS FACTS More than 9 million people fall sick with tuberculosis (TB) every year. Over 1.5 million die

More information

Pills for Type 2 Diabetes. A Guide for Adults

Pills for Type 2 Diabetes. A Guide for Adults Pills for Type 2 Diabetes A Guide for Adults December 2007 Fast Facts on Diabetes Pills n Different kinds of diabetes pills work in different ways to control blood sugar (blood glucose). n All the diabetes

More information

Department Of Biochemistry. Subject: Diabetes Mellitus. Supervisor: Dr.Hazim Allawi & Dr.Omar Akram Prepared by : Shahad Ismael. 2 nd stage.

Department Of Biochemistry. Subject: Diabetes Mellitus. Supervisor: Dr.Hazim Allawi & Dr.Omar Akram Prepared by : Shahad Ismael. 2 nd stage. Department Of Biochemistry Subject: Diabetes Mellitus Supervisor: Dr.Hazim Allawi & Dr.Omar Akram Prepared by : Shahad Ismael. 2 nd stage. Diabetes mellitus : Type 1 & Type 2 What is diabestes mellitus?

More information

Insulin Resistance and Pre-diabetes

Insulin Resistance and Pre-diabetes 1 of 6 11/17/2009 9:38 PM Insulin Resistance and Pre-diabetes What is insulin resistance? What causes insulin resistance? Metabolic Syndrome What is pre-diabetes? What are the symptoms of insulin resistance

More information

Medications and Diabetes

Medications and Diabetes monitor track manage A TRUEinsight Guide manage Medications and Diabetes Understanding the Importance of Oral Medications The importance of oral medications Understanding the importance of oral medications

More information

Introduction. Pathogenesis of type 2 diabetes

Introduction. Pathogenesis of type 2 diabetes Introduction Type 2 diabetes mellitus (t2dm) is the most prevalent form of diabetes worldwide. It is characterised by high fasting and high postprandial blood glucose concentrations (hyperglycemia). Chronic

More information

Faculty. Program Objectives. Introducing the Problem. Diabetes is a Silent Killer. Minorities at Greater Risk of Having Type 2 Diabetes

Faculty. Program Objectives. Introducing the Problem. Diabetes is a Silent Killer. Minorities at Greater Risk of Having Type 2 Diabetes Diabetes: The Basics Understanding and Managing Diabetes (Part 1 of 3) Satellite Conference Tuesday, October 18, 2005 2:00-4:00 p.m. (Central Time) Produced by the Alabama Department of Public Health Video

More information

Type 2 Diabetes Fact Sheet

Type 2 Diabetes Fact Sheet Type 2 Diabetes Fact Sheet Diabetes Overview Diabetes is a chronic disease characterized by high blood glucose levels (hyperglycemia) that results from the inability of the body to properly use and/or

More information

CHAPTER V DISCUSSION. normal life provided they keep their diabetes under control. Life style modifications

CHAPTER V DISCUSSION. normal life provided they keep their diabetes under control. Life style modifications CHAPTER V DISCUSSION Background Diabetes mellitus is a chronic condition but people with diabetes can lead a normal life provided they keep their diabetes under control. Life style modifications (LSM)

More information

DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study

DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study National Diabetes Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH What

More information

Metabolic Diseases: Obesity, Hyperlipidemia, and Diabetes

Metabolic Diseases: Obesity, Hyperlipidemia, and Diabetes Metabolic Diseases: Obesity, Hyperlipidemia, and Diabetes Obesity Approximately 1 in 3 adults are overweight in the U.S. Arizona According to CDC, Arizona has highest reported percentage of adults who

More information

DRUGS FOR GLUCOSE MANAGEMENT AND DIABETES

DRUGS FOR GLUCOSE MANAGEMENT AND DIABETES Page 1 DRUGS FOR GLUCOSE MANAGEMENT AND DIABETES Drugs to know are: Actrapid HM Humulin R, L, U Penmix SUNALI MEHTA The three principal hormones produced by the pancreas are: Insulin: nutrient metabolism:

More information

The Family Library. Understanding Diabetes

The Family Library. Understanding Diabetes The Family Library Understanding Diabetes What is Diabetes? Diabetes is caused when the body has a problem in making or using insulin. Insulin is a hormone secreted by the pancreas and is needed for the

More information

trends in the treatment of Diabetes type 2 - New classes of antidiabetic drugs. IAIM, 2015; 2(4): 223-

trends in the treatment of Diabetes type 2 - New classes of antidiabetic drugs. IAIM, 2015; 2(4): 223- Review Article Pharmacological trends in the treatment of Diabetes type 2 - New classes of antidiabetic Silvia Mihailova 1*, Antoaneta Tsvetkova 1, Anna Todorova 2 1 Assistant Pharmacist, Education and

More information

X-Plain Hypoglycemia Reference Summary

X-Plain Hypoglycemia Reference Summary X-Plain Hypoglycemia Reference Summary Introduction Hypoglycemia is a condition that causes blood sugar level to drop dangerously low. It mostly shows up in diabetic patients who take insulin. When recognized

More information

Post-Transplant Diabetes: What Every Patient Needs to Know

Post-Transplant Diabetes: What Every Patient Needs to Know Post-Transplant Diabetes: What Every Patient Needs to Know International Transplant Nurses Society What is Diabetes? Diabetes is an illness that effects how your body makes and uses a hormone called insulin.

More information

CASE A1 Hypoglycemia in an Elderly T2DM Patient with Heart Failure

CASE A1 Hypoglycemia in an Elderly T2DM Patient with Heart Failure Hypoglycemia in an Elderly T2DM Patient with Heart Failure 1 I would like to introduce you to Sophie, an elderly patient with long-standing type 2 diabetes, who has a history of heart failure, a common

More information

Practice Guidelines for the

Practice Guidelines for the 1 Treatment goals: Practice Guidelines for the The goal of treatment is to keep blood sugar at normal or near-normal levels. This reduces the risk of complications associated with diabetes. A normal fasting

More information

WORKING TOGETHER TO MANAGE DIABETES

WORKING TOGETHER TO MANAGE DIABETES WORKING TOGETHER TO MANAGE DIABETES DIABETES MEDICATIONS SUPPLEMENT SECTION A DIABETES MEDICATIONS Agent Class Primary Action Typical Dosage Side Effects Tolbutamide (Ornase TM ) Tolazamide (Tolinase TM

More information

Disability Evaluation Under Social Security

Disability Evaluation Under Social Security Disability Evaluation Under Social Security Revised Medical Criteria for Evaluating Endocrine Disorders Effective June 7, 2011 Why a Revision? Social Security revisions reflect: SSA s adjudicative experience.

More information

Welcome to Diabetes Education! Why Should I Take Control of My Diabetes?

Welcome to Diabetes Education! Why Should I Take Control of My Diabetes? Welcome to Diabetes Education! Why Should I Take Control of My Diabetes? NEEDS and BENEFITS of SELF-MANAGEMENT You make choices about your life and health Controlling diabetes needs every day decisions

More information

Diabetes: Medications

Diabetes: Medications Diabetes: Medications Presented by: APS Healthcare Southwestern PA Health Care Quality Unit (APS HCQU) May 2008 sh Disclaimer Information or education provided by the HCQU is not intended to replace medical

More information

Clinical Practice Guidelines for Diabetes Management

Clinical Practice Guidelines for Diabetes Management Clinical Practice Guidelines for Diabetes Management Diabetes is a disease in which blood glucose levels are above normal. Over the years, high blood glucose damages nerves and blood vessels, which can

More information

Take a moment Confer with your neighbour And try to solve the following word picture puzzle slides.

Take a moment Confer with your neighbour And try to solve the following word picture puzzle slides. Take a moment Confer with your neighbour And try to solve the following word picture puzzle slides. Example: = Head Over Heels Take a moment Confer with your neighbour And try to solve the following word

More information

My Doctor Says I Need to Take Diabetes Pills and Insulin... What Do I Do Now? BD Getting Started. Combination Therapy

My Doctor Says I Need to Take Diabetes Pills and Insulin... What Do I Do Now? BD Getting Started. Combination Therapy My Doctor Says I Need to Take Diabetes Pills and Insulin... What Do I Do Now? BD Getting Started Combination Therapy How Can Combination Therapy Help My Type 2 Diabetes? When you have type 2 diabetes,

More information

Markham Stouffville Hospital

Markham Stouffville Hospital Markham Stouffville Hospital Adult Diabetes Education Frequently Asked Questions What is diabetes? Diabetes is a disease in which blood glucose levels are above normal. Most of the food we eat is turned

More information

Medicines Used to Treat Type 2 Diabetes

Medicines Used to Treat Type 2 Diabetes Goodman Diabetes Service Medicines Used to Treat Type 2 Diabetes People who have type 2 diabetes may need to take medicine to help lower their blood glucose, in addition to being active & choosing healthy

More information

Guidelines for the management of hypertension in patients with diabetes mellitus

Guidelines for the management of hypertension in patients with diabetes mellitus Guidelines for the management of hypertension in patients with diabetes mellitus Quick reference guide In the Eastern Mediterranean Region, there has been a rapid increase in the incidence of diabetes

More information

Diabetes Brief. Pre diabetes occurs when glucose levels are elevated in the blood, but are not as high as someone who has diabetes.

Diabetes Brief. Pre diabetes occurs when glucose levels are elevated in the blood, but are not as high as someone who has diabetes. Diabetes Brief What is Diabetes? Diabetes mellitus is a disease of abnormal carbohydrate metabolism in which the level of blood glucose, or blood sugar, is above normal. The disease occurs when the body

More information

Pharmaceutical Management of Diabetes Mellitus

Pharmaceutical Management of Diabetes Mellitus 1 Pharmaceutical Management of Diabetes Mellitus Diabetes Mellitus (cont d) Signs and symptoms 2 Elevated fasting blood glucose (higher than 126 mg/dl) or a hemoglobin A1C (A1C) level greater than or equal

More information

DIABETES MELLITUS. By Tracey Steenkamp Biokineticist at the Institute for Sport Research, University of Pretoria

DIABETES MELLITUS. By Tracey Steenkamp Biokineticist at the Institute for Sport Research, University of Pretoria DIABETES MELLITUS By Tracey Steenkamp Biokineticist at the Institute for Sport Research, University of Pretoria What is Diabetes Diabetes Mellitus (commonly referred to as diabetes ) is a chronic medical

More information

Pharmacologic Therapy for Type 2 Diabetes Mellitus

Pharmacologic Therapy for Type 2 Diabetes Mellitus REVIEW Pharmacologic Therapy for Type 2 Diabetes Mellitus Ralph A. DeFronzo, MD Type 2 diabetes mellitus is a chronic metabolic disorder that results from defects in both insulin secretion and insulin

More information

Treatment of diabetes In order to survive, people with type 1 diabetes must have insulin delivered by a pump or injections.

Treatment of diabetes In order to survive, people with type 1 diabetes must have insulin delivered by a pump or injections. National Diabetes Statistics What is diabetes? Diabetes mellitus is a group of diseases characterized by high levels of blood glucose resulting from defects in insulin production, insulin action, or both.

More information

Diabetes Mellitus 1. Chapter 43. Diabetes Mellitus, Self-Assessment Questions

Diabetes Mellitus 1. Chapter 43. Diabetes Mellitus, Self-Assessment Questions Diabetes Mellitus 1 Chapter 43. Diabetes Mellitus, Self-Assessment Questions 1. A 46-year-old man presents for his annual physical. He states that he has been going to the bathroom more frequently than

More information

Section 2. Overview of Obesity, Weight Loss, and Bariatric Surgery

Section 2. Overview of Obesity, Weight Loss, and Bariatric Surgery Section 2 Overview of Obesity, Weight Loss, and Bariatric Surgery What is Weight Loss? How does surgery help with weight loss? Short term versus long term weight loss? Conditions Improved with Weight Loss

More information

Diabetes, Type 2. RelayClinical Patient Education Sample Topic Diabetes, Type 2. What is type 2 diabetes? How does it occur?

Diabetes, Type 2. RelayClinical Patient Education Sample Topic Diabetes, Type 2. What is type 2 diabetes? How does it occur? What is type 2 diabetes? Type 2 diabetes is a disorder that happens when your body does not make enough insulin or is unable to use its own insulin properly. The inability to use insulin is called insulin

More information

Medicines for Type 2 Diabetes A Review of the Research for Adults

Medicines for Type 2 Diabetes A Review of the Research for Adults Medicines for Type 2 Diabetes A Review of the Research for Adults Is This Information Right for Me? Yes, if: Your doctor or health care provider has told you that you have type 2 diabetes and have high

More information

Management of Diabetes in the Elderly. Sylvia Shamanna Internal Medicine (R1)

Management of Diabetes in the Elderly. Sylvia Shamanna Internal Medicine (R1) Management of Diabetes in the Elderly Sylvia Shamanna Internal Medicine (R1) Case 74 year old female with frontal temporal lobe dementia admitted for prolonged delirium and frequent falls (usually in the

More information

Type 2 Diabetes. What is diabetes? Understanding blood glucose and insulin. What is Type 2 diabetes? Page 1 of 5

Type 2 Diabetes. What is diabetes? Understanding blood glucose and insulin. What is Type 2 diabetes? Page 1 of 5 Page 1 of 5 Type 2 Diabetes Type 2 diabetes occurs mainly in people aged over 40. The 'first-line' treatment is diet, weight control and physical activity. If the blood glucose level remains high despite

More information

Type 2 Diabetes Medicines: What You Need to Know

Type 2 Diabetes Medicines: What You Need to Know Type 2 Diabetes Medicines: What You Need to Know Managing diabetes is complex because many hormones and body processes are at work controlling blood sugar (glucose). Medicines for diabetes include oral

More information

Medical Assistant s Diabetes Survey

Medical Assistant s Diabetes Survey Medical Assistant s Diabetes Survey Instructions: Circle one answer for each question. Thank-you. Basic Knowledge 1. Risk factors for developing Type 2 diabetes include: a. Family members with diabetes

More information

An Overview of Medicare Covered Diabetes Supplies and Services

An Overview of Medicare Covered Diabetes Supplies and Services News Flash - Understanding the Remittance Advice: A Guide for Medicare Providers, Physicians, Suppliers, and Billers serves as a resource on how to read and understand a Remittance Advice (RA). Inside

More information

How do oral medications work?...50 How many pills will I have to take?...51

How do oral medications work?...50 How many pills will I have to take?...51 taking medication taking medication medication medication medication medication medication Diabetes medications come in two broad categories, oral medications (pills) and injectable medications (shots).

More information

Type 2 Diabetes Mellitus and Insulin resistance syndrome in Children

Type 2 Diabetes Mellitus and Insulin resistance syndrome in Children Type 2 Diabetes Mellitus and Insulin resistance syndrome in Children Anil R Kumar MD Pediatric Endocrinology MCV/VCU, Richmond VA Introduction Type 2 diabetes mellitus (T2 DM) has increased in children

More information

PowerPoint Lecture Outlines prepared by Dr. Lana Zinger, QCC CUNY. 12a. FOCUS ON Your Risk for Diabetes. Copyright 2011 Pearson Education, Inc.

PowerPoint Lecture Outlines prepared by Dr. Lana Zinger, QCC CUNY. 12a. FOCUS ON Your Risk for Diabetes. Copyright 2011 Pearson Education, Inc. PowerPoint Lecture Outlines prepared by Dr. Lana Zinger, QCC CUNY 12a FOCUS ON Your Risk for Diabetes Your Risk for Diabetes! Since 1980,Diabetes has increased by 50 %. Diabetes has increased by 70 percent

More information

Cardiovascular Disease Risk Factors Part XII Insulin Resistance By James L. Holly, MD Your Life Your Health The Examiner September 15, 2005

Cardiovascular Disease Risk Factors Part XII Insulin Resistance By James L. Holly, MD Your Life Your Health The Examiner September 15, 2005 Cardiovascular Disease Risk Factors Part XII By James L. Holly, MD Your Life Your Health The Examiner September 15, 2005 As we approach the end of our extended series on cardiovascular disease risk factors,

More information

ACTOS (pioglitazone HCl) in the Management of Type 2 Diabetes PRODUCT INFORMATION GUIDE

ACTOS (pioglitazone HCl) in the Management of Type 2 Diabetes PRODUCT INFORMATION GUIDE MARCH 2008 PRODUCT INFORMATION GUIDE JIM DOWDALLS / PHOTO RESEARCHERS, INC. ACTOS (pioglitazone HCl) in the Management of Type 2 Diabetes PHG0801 SPECIAL ADVERTISING SECTION This Product Information Guide

More information

Strengthening the Pharmacist Skills in Managing Diabetes Practice Based Program 27 Contact Hours

Strengthening the Pharmacist Skills in Managing Diabetes Practice Based Program 27 Contact Hours Strengthening the Pharmacist Skills in Managing Diabetes Practice Based Program 27 Contact Hours Presented by New York State Council of Health system Pharmacists October 18 19, 2013 St. John s University,

More information

Glucose Tolerance Testing

Glucose Tolerance Testing Glucose Tolerance Testing PROTOCOLS FOR PERFORMING GLUCOSE TOLERANCE TESTS INTRODUCTION Described in this section are the sample requirements, patient preparation instructions, dosages of substances to

More information

ETIOLOGIC CLASSIFICATION. Type I diabetes Type II diabetes

ETIOLOGIC CLASSIFICATION. Type I diabetes Type II diabetes DIABETES MELLITUS DEFINITION It is a common, chronic, metabolic syndrome characterized by hyperglycemia as a cardinal biochemical feature. Resulting from absolute lack of insulin. Abnormal metabolism of

More information

Comparing Medications for Adults With Type 2 Diabetes Focus of Research for Clinicians

Comparing Medications for Adults With Type 2 Diabetes Focus of Research for Clinicians Clinician Research Summary Diabetes Type 2 Diabetes Comparing Medications for Adults With Type 2 Diabetes Focus of Research for Clinicians A systematic review of 166 clinical studies published between

More information

If diabetes is not treated it can cause long-term health problems because the high glucose levels in the blood damage the blood vessels.

If diabetes is not treated it can cause long-term health problems because the high glucose levels in the blood damage the blood vessels. INFORMATION FOR PEOPLE WITH DIABETES Diabetes Diabetes mellitus is a chronic condition caused by too much glucose (sugar) in your blood. Your blood sugar level can be too high if your body does not make

More information

X-Plain Diabetes - Introduction Reference Summary

X-Plain Diabetes - Introduction Reference Summary X-Plain Diabetes - Introduction Reference Summary Introduction Diabetes is a disease that affects millions of Americans every year. Your doctor may have informed you that you have diabetes. Although there

More information

Management of Clients with Diabetes Mellitus

Management of Clients with Diabetes Mellitus Management of Clients with Diabetes Mellitus Black, J.M. & Hawks, J.H. (2005) Chapters 47, (pp 1243-1288) 1288) Baptist Health School of Nursing NSG 4037: Adult Nursing III Carole Mackey, MNSc,, RN, PNP

More information

Chapter 15: Diabetes Mellitus

Chapter 15: Diabetes Mellitus Chapter 15: Diabetes Mellitus 15.1: SCREENING FOR NEW-ONSET DIABETES AFTER TRANSPLANTATION 15.1.1: We recomme screening all noiabetic KTRs with fasting plasma glucose, oral glucose tolerance testing, a/or

More information

LOW T NATION TESTOSTERONE INTAKE FORM NAME: DATE: ADDRESS: CITY: STATE: ZIP: CELL #: HOME #: SOC SECURITY #: DATE OF BIRTH:

LOW T NATION TESTOSTERONE INTAKE FORM NAME: DATE: ADDRESS: CITY: STATE: ZIP: CELL #: HOME #: SOC SECURITY #: DATE OF BIRTH: LOW T NATION TESTOSTERONE INTAKE FORM NAME: DATE: ADDRESS: CITY: STATE: ZIP: CELL #: HOME #: SOC SECURITY #: DATE OF BIRTH: DRIVERS LICENSE NUMBER: STATE: EMAIL ADDRESS: MARITAL STATUS: ( ) SINGLE ( )

More information

Britni Hebert, MD PGY-1

Britni Hebert, MD PGY-1 Britni Hebert, MD PGY-1 Importance of Diabetes treatment Types of treatment Comparison of treatment/article Review Summary Example cases 1 out of 13 Americans have diabetes Complications include blindness,

More information

Diabetes Medications: Insulin Therapy

Diabetes Medications: Insulin Therapy Diabetes Medications: Insulin Therapy Courtesy Univ Texas San Antonio Eric L. Johnson, M.D. Department of Family and Community Medicine Diabetes and Insulin Type 1 Diabetes Autoimmune destruction of beta

More information

Welchol (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes

Welchol (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes For Immediate Release Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Takashi Shoda, President and Representative Director (Code no.: 4568, First Section, Tokyo, Osaka and Nagoya Stock Exchanges)

More information

Inpatient Treatment of Diabetes

Inpatient Treatment of Diabetes Inpatient Treatment of Diabetes Alan J. Conrad, MD Medical Director Diabetes Services EVP, Physician Alignment Diabetes Symposium November 12, 2015 Objectives Explain Palomar Health goals for inpatient

More information

PATHWAYS TO TYPE 2 DIABETES. Vera Tsenkova, PhD Assistant Scientist Institute on Aging University of Wisconsin-Madison

PATHWAYS TO TYPE 2 DIABETES. Vera Tsenkova, PhD Assistant Scientist Institute on Aging University of Wisconsin-Madison PATHWAYS TO TYPE 2 DIABETES Vera Tsenkova, PhD Assistant Scientist Institute on Aging University of Wisconsin-Madison Overview Diabetes 101 How does diabetes work Types of diabetes Diabetes in numbers

More information

Improving drug prescription in elderly diabetic patients. FRANCESC FORMIGA Hospital Universitari de Bellvitge

Improving drug prescription in elderly diabetic patients. FRANCESC FORMIGA Hospital Universitari de Bellvitge Improving drug prescription in elderly diabetic patients FRANCESC FORMIGA Hospital Universitari de Bellvitge High prevalence, but also increases the incidence. The older the patients, the higher the percentages

More information

Diabetes 101. Francisco J. Prieto, M.D. American Diabetes Association National Advocacy Committee Latino Diabetes Action Council

Diabetes 101. Francisco J. Prieto, M.D. American Diabetes Association National Advocacy Committee Latino Diabetes Action Council Diabetes 101 Francisco J. Prieto, M.D. American Diabetes Association National Advocacy Committee Latino Diabetes Action Council www.diabetes.org 1-800-DIABETES www.diabetes.org 1-800-DIABETES Age-Adjusted

More information

GUIDELINES FOR THE TREATMENT OF DIABETIC NEPHROPATHY*

GUIDELINES FOR THE TREATMENT OF DIABETIC NEPHROPATHY* 71 GUIDELINES FOR THE TREATMENT OF DIABETIC NEPHROPATHY* Ryuichi KIKKAWA** Asian Med. J. 44(2): 71 75, 2001 Abstract: Diabetic nephropathy is the most devastating complication of diabetes and is now the

More information

Criteria: CWQI HCS-123 (This criteria is consistent with CMS guidelines for External Infusion Insulin Pumps)

Criteria: CWQI HCS-123 (This criteria is consistent with CMS guidelines for External Infusion Insulin Pumps) Moda Health Plan, Inc. Medical Necessity Criteria Subject: Origination Date: 05/15 Revision Date(s): 05/2015 Developed By: Medical Criteria Committee 06/24/2015 External Infusion Insulin Pumps Page 1 of

More information

Type 1 Diabetes. Pennington Nutrition Series. Overview. About Insulin

Type 1 Diabetes. Pennington Nutrition Series. Overview. About Insulin Pennington Nutrition Series Healthier lives through education in nutrition and preventive medicine Pub No. 32 Type 1 Diabetes Overview Type 1 Diabetes (DM) is usually diagnosed in children and young adults.

More information

written by Harvard Medical School Insulin Therapy Managing Your Diabetes www.patientedu.org

written by Harvard Medical School Insulin Therapy Managing Your Diabetes www.patientedu.org written by Harvard Medical School Insulin Therapy Managing Your Diabetes www.patientedu.org What Is Insulin? The cells of your body need energy and one source of energy is sugar in your blood. Insulin

More information

Common Drug Review Patient Group Input Submissions

Common Drug Review Patient Group Input Submissions Common Drug Review Patient Group Input Submissions Canagliflozin (Invokana) for Diabetes Mellitus, Type 2 Patient group input submissions were received from the following patient groups. Those with permission

More information

INITIATING ORAL AUBAGIO (teriflunomide) THERAPY

INITIATING ORAL AUBAGIO (teriflunomide) THERAPY FOR YOUR PATIENTS WITH RELAPSING FORMS OF MS INITIATING ORAL AUBAGIO (teriflunomide) THERAPY WARNING: HEPATOTOXICITY AND RISK OF TERATOGENICITY Severe liver injury including fatal liver failure has been

More information

Introduction. We hope this guide will aide you and your staff in creating a safe and supportive environment for your students challenged by diabetes.

Introduction. We hope this guide will aide you and your staff in creating a safe and supportive environment for your students challenged by diabetes. Introduction Diabetes is a chronic disease that affects the body s ability to metabolize food. The body converts much of the food we eat into glucose, the body s main source of energy. Glucose is carried

More information

A Simplified Approach to Initiating Insulin. 4. Not meeting glycemic goals with oral hypoglycemic agents or

A Simplified Approach to Initiating Insulin. 4. Not meeting glycemic goals with oral hypoglycemic agents or A Simplified Approach to Initiating Insulin When to Start Insulin: 1. Fasting plasma glucose (FPG) levels >250 mg/dl or 2. Glycated hemoglobin (A1C) >10% or 3. Random plasma glucose consistently >300 mg/dl

More information

Type 2 Diabetes Type 2 Diabetes

Type 2 Diabetes Type 2 Diabetes Pennington Nutrition Series Healthier lives through education in nutrition and preventive medicine Pub No. 33 Type 2 is the most common form of diabetes. In this form, the body does not produce enough

More information

CASE B1. Newly Diagnosed T2DM in Patient with Prior MI

CASE B1. Newly Diagnosed T2DM in Patient with Prior MI Newly Diagnosed T2DM in Patient with Prior MI 1 Our case involves a gentleman with acute myocardial infarction who is newly discovered to have type 2 diabetes. 2 One question is whether anti-hyperglycemic

More information

ICD 10 CM. Diabetes Mellitus Hypertension

ICD 10 CM. Diabetes Mellitus Hypertension ICD 10 CM Diabetes Mellitus Hypertension 1 Legal Stuff The information provided here is personal opinion only and should not be construed as legal advice. Each provider is ultimately responsible for bills

More information

Investigation of the effect of isomaltulose (PalatinoseTM) on metabolic parameters in subjects with Type 2 Diabetes.

Investigation of the effect of isomaltulose (PalatinoseTM) on metabolic parameters in subjects with Type 2 Diabetes. PLEASE NOTE: This trial has been registered retrospectively. Trial Description Title Investigation of the effect of isomaltulose (PalatinoseTM) on metabolic parameters in subjects with Type 2 Diabetes.

More information

Manitoba EMR Data Extract Specifications

Manitoba EMR Data Extract Specifications MANITOBA HEALTH Manitoba Data Specifications Version 1 Updated: August 14, 2013 1 Introduction The purpose of this document 1 is to describe the data to be included in the Manitoba Data, including the

More information